Cadila Covid Vaccine

• 

  Zydus Cadila Begins Supply Of Covid Vaccine ZyCoV-D To Government

  Pharmaceutical company Zydus on Wednesday announced that it has started the supplies of its COVID-19 vaccine ZyCoV-D to the Government of India against their order from its newly commissioned state-of-the-art.

• 

  Zydus Cadila's Covid Vaccine ZyCoV-D To Be Used In 7 States Initially

  Zydus Cadila's Covid vaccine ZyCoV-D will initially be used in 7 states, including Maharashtra, Tamil Nadu, UP and Bengal, which have been recommended to identify the districts with a high number of people who have not received a single dose yet.

• 

  South Korea's Enzychem To Make Cadila's COVID-19 Shot

  South Korea's Enzychem Lifesciences would make at least 80 million doses of India's homegrown DNA COVID-19 vaccine from Cadila Healthcare, the Indian drugmaker said on Wednesday.

• 

  India To Buy 1 Crore Zydus Cadila 'Needle-Free' Covid Shots At Rs 265 Each

  The indigenously developed world's first DNA-based needle-free COVID-19 vaccine ZyCoV-D received emergency use authorisation from the drug regulator on August 20.

• 

  Zydus Cadila Agrees To Reduce Covid Vaccine Price To Rs 265 Per Dose: Report

  Zydus Cadila's ZyCov-D is the first vaccine cleared by India's drug regulator for inoculation of those aged 12 years and above

• 

  Zydus Cadila's ZyCoV-D To Be Introduced In Covid Vaccine Drive Shortly: Centre

  The government today said Zydus Cadila's indigenously-developed needle-free Covid vaccine ZyCoV-D will be introduced in the nationwide vaccination drive very shortly and will be differentially priced than the jabs being used currently.

• 

  Talks On To Make Covid DNA Vaccine Part Of Inoculation Drive: Centre

  Preparations are on to make Zydus Cadila's COVID-19 DNA vaccine available to people and although the price is a "clear issue", a decision will be taken soon to make it a part of the country's vaccination programme, the government said on Thursday.

• 

  Cadila Healthcare Surges On Receiving Emergence Use Approval For COVID Vaccine

  ZyCoV-D is a needle-free vaccine administered using The PharmaJet a needle free applicator, which ensures painless intradermal vaccine delivery.

• 

  Stocks To Watch: Cadila Healthcare, Infosys, HDFC Bank

  Zydus Cadila's Covid vaccine, ZyCoV-D, has received approval for emergency use authorization from the Drug Controller General of India

• 

  Zydus Cadila Says "More Clarity" On Its Covid Vaccine Price By Next Week

  There will be more clarity on the prices of COVID-19 vaccine ZyCOV-D by next week, Zydus Group Managing Director Dr Sharvil Patel said today.

• 

  Zydus To Produce 1 Crore Doses Per Month By October, Says Chief

  Zydus Cadila, whose Covid vaccine ZyCoV-D for adults and children aged 12 years and above got approval yesterday, said it hopes to produce one crore doses per month by October.

• 

  A Momentous Feat: PM After Zydus Cadila's Covid Vaccine Gets Emergency Use Authorisation

  Prime Minister Narendra Modi on Friday hailed it as a "momentous feat" and said the approval to the world's first DNA-based vaccine against the coronavirus is a testimony to the innovative zeal of India's scientists.

• 

  "3 Doses, 66 Per Cent Efficacy": 5 Things To Know About Zydus Cadila's Covid Vaccine For Children

  Zydus Cadila's Covid vaccine ZyCoV-D, meant for adults and children aged 12 years and above, was today approved for "restricted use in emergency situation" by the Central Drugs Standard Control Organisation (CDSCO).

• 

  1st Covid Vaccine For Children Above 12 Approved In India

  India's drug regulator on Friday approved Zydus Cadila's three-dose COVID-19 DNA vaccine for emergency use in adults and children aged 12 years and above, bringing in the sixth vaccine authorised for use in the country.

• 

  Cadila Healthcare Net Profit Rises 29% To Rs 587 Crore In June Quarter

  Cadila Healthcare's total revenue from operations in the first quarter of the current fiscal stood at Rs 4,025.4 crore, compared to Rs 3,514.6 crore in the year-ago period